Qube Research & Technologies (QRT)’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-124,646
Closed -$2.72M 3524
2025
Q4
$2.72M Sell
124,646
-78,943
-39% -$1.64M ﹤0.01% 2112
2025
Q3
$4.37M Buy
203,589
+445
+0.2% +$9.98K ﹤0.01% 1838
2025
Q2
$5.21M Buy
203,144
+50,564
+33% +$1.48M 0.01% 1673
2025
Q1
$5.58M Sell
152,580
-26,235
-15% -$902K 0.01% 1464
2024
Q4
$5.48M Buy
178,815
+19,703
+12% +$655K 0.01% 1436
2024
Q3
$5.99M Buy
159,112
+155,222
+3,990% +$5.98M 0.01% 1298
2024
Q2
$154K Sell
3,890
-6,832
-64% -$221K ﹤0.01% 2503
2024
Q1
$360K Buy
+10,722
New +$360K ﹤0.01% 2716
2020
Q3
Sell
-6,312
Closed -$286K 1667
2020
Q2
$286K Buy
+6,312
New +$323K ﹤0.01% 1319

Other funds holding ATEX

Qube Research & Technologies (QRT)'s ATEX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Anterix (ATEX) in Q1 2026, closing a stake of 124,646 shares — an estimated $2.72M sold.

Qube Research & Technologies (QRT) first reported a position in ATEX in Q2 2020 and held it in 9 quarters. The position peaked at $5.99M in Q3 2024. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 124,646 Anterix shares in Q1 2026, an estimated $2.72M.
  • Qube Research & Technologies (QRT) first reported a position in Anterix in Q2 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Anterix position peaked at $5.99M in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.